Biocartis spins out life sciences multiplex platform Evalution into MyCartis
September 4, 2014
Mechelen (Belgium)-- Biocartis, an innovative molecular diagnostics company, announced today that it has combined its Swiss Evalution(1)(2) business unit with Belgian-based Pronota NV to jointly form MyCartis(2). MyCartis also completed an EUR 15 million equity round. Biocartis’ Evalution platform, previously known as DMAT, is designed for rapid and cost- effective detection of a broad range [...]
September 4, 2014
Victoria, BC -- GenoLogics today announced it has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing system customers. Under the agreement, the companies are working closely to provide support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those to be used inside [...]
September 4, 2014
Sunnyvale, CA -- Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced the CM Protégé PharmD System will now support reaction screening and optimization. The CM Protégé PharmD System is an automated platform that supports a wide range of drug development applications, including high throughput polymorph, salt, co-crystal, and [...]
September 3, 2014
Fort Atkinson, Wis. -– Digi-Star LLC has formed a Near-infrared (NIR) partnership with Dinamica Generale S.p.A. to offer multiple NIR product solutions to North American producers. In addition to a portable NIR Moisture testing device, Digi-Star is now distributing two NIR feedstuff analyzing tools. Allowing farmers to gain near instantaneous dry matter, starch, crude protein [...]
September 3, 2014
CINCINNATI -- Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene® molecular menu of tests to its members. Premier serves more than 3,000 U.S. hospitals and 110,000-plus other healthcare sites. This agreement offers each Premier healthcare facility the opportunity to implement rapid, [...]
Teledyne Announces Accelerated Share Repurchase
September 3, 2014
THOUSAND OAKS, California -- Teledyne Technologies Incorporated (NYSE:TDY) today announced that it has entered into an accelerated share repurchase agreement with a financial institution to repurchase 1,030,000 shares of Teledyne's common stock, pursuant to the company's previously announced share repurchase program. The estimated value of the accelerated repurchase transaction is approximately $100 million. Under Teledyne's [...]
Xylem wins $7.3 million contract with Bahrain Ministry of Works
September 3, 2014
RYE BROOK, N.Y.-- Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that it has signed a $7.3 million contract with Bahrain’s Ministry of Works to upgrade a wastewater treatment facility in Manama, the capital city of Bahrain. Under the contract, Xylem will design, [...]
September 3, 2014
SUNNYVALE, Calif.-- Cepheid (NASDAQ: CPHD) today announced the release of Xpert® TV, an on-demand molecular test for rapid, accurate and reproducible identification of Trichomoniasis (TV) infections in both males and females. The test will be marketed as a CE-IVD product under the European Directive on In Vitro Diagnostic Medical Devices, bringing the total number of [...]
September 3, 2014
SAN JOSE, Calif. –– European laboratories testing feed and food for dioxins and dioxin-like substances now have lower-cost, smaller-footprint alternatives to high-resolution mass spectrometers (HRMS) for confirming levels of the toxic contaminants, thanks to a new European Union regulation. Thermo Fisher Scientific worked closely with national reference labs (NRLs) in the European Union to support [...]
Simulations Plus Closes Acquisition of Cognigen Corporation
September 3, 2014
LANCASTER, Calif.-- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that the Agreement and Plan of Merger (the “Agreement”) with Cognigen Corporation of Buffalo, New York, announced on July 23, 2014, has been closed as of today and the two companies are now [...]
